Dr B Pharmaceutical Private Limited - Due diligence report
A 360° intelligence report on Dr B Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, growth…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Dr B Pharmaceutical Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsDr B Pharmaceutical Private Limited is assessed as Low Risk with a Trust Score of 85/100. Dr B Pharmaceutical Private Limited is an active private limited indian non-government company incorporated in 2023, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 10 Oct 2026 from the latest processed filings. Dr B Pharmaceutical Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- No balance-sheet filing date on record.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| PROSENJIT DEBNATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RATAN DEBNATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 3 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Funcity Infrastructure Limited | U70102AS2012PLC017742 | Cachar, Assam |
| Mephix Healthcare Private Limited | U47721AS2024PTC027267 | Cachar, Assam |
| Fourace Mutual Benefit India Limited | U65991AS2012PLC011300 | Cachar, Assam |
| Portico Global (Opc) Private Limited | U46901AS2023OPC025415 | Cachar, Assam |
| Varcas Humanitarian Foundation | U85300AS2019NPL019203 | Cachar, Assam |
| Starlife Devcon Private Limited | U45201AS2010PTC010124 | Cachar, Assam |
| Ihlrl Express Riders Private Limited | U74999AS2018PTC018384 | Cachar, Assam |
| Asshash Micro Service Foundation | U88900AS2025NPL027571 | Cachar, Assam |
| Thijarat Constructions Private Limited | U45201AS2010PTC009932 | Cachar, Assam |
| Biomed Hospital & Research Centre Private Limited | U85110AS2009PTC009219 | Cachar, Assam |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Dr B Pharmaceutical Private Limited before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Dr B Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Dr B Pharmaceutical Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 85/100, distress signals and MSME payment-delay disclosures - know whether Dr B Pharmaceutical Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dr B Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Dr B Pharmaceutical Private Limited an active company?
Dr B Pharmaceutical Private Limited has MCA status “Active” with a compliance score of 90/100 (Low Risk).
Is Dr B Pharmaceutical Private Limited financially healthy?
Processed financial statements are not yet available for Dr B Pharmaceutical Private Limited, so its financial health is unassessed.
Should I do business with Dr B Pharmaceutical Private Limited?
Its overall Trust Score is 85/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Dr B Pharmaceutical Private Limited?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Dr B Pharmaceutical Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Dr B Pharmaceutical Private Limited up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).
Is it risky to lend to Dr B Pharmaceutical Private Limited?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.